Healx Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 69

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $2M

  • Investors
  • 26

Healx General Information

Description

Developer of an artificial intelligence-driven drug discovery technology designed to create treatments for rare diseases. The company offers a combination of frontier machine learning technology and drug discovery expertise, enabling clients to accelerate the development of novel treatments and improve the success rate for addressing the unmet needs of rare disease patients worldwide.

Contact Information

Website
www.healx.ai
Formerly Known As
Healx3
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3rd Floor Charter House
  • 66-68 Hills Road
  • Cambridge CB2 1LA
  • England, United Kingdom
+44 01223
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Corporate Office
  • 3rd Floor Charter House
  • 66-68 Hills Road
  • Cambridge CB2 1LA
  • England, United Kingdom
+44 01223

Healx Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Healx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 15-Jul-2025 $2M Completed Clinical Trials - Phase 1
7. Later Stage VC (Series C) 01-Aug-2024 Completed Clinical Trials - Phase 1
6. Later Stage VC (Series B) 16-Oct-2019 Completed Clinical Trials - General
5. Early Stage VC (Series A) 26-Jul-2018 Completed Clinical Trials - General
4. Early Stage VC (Series A) 05-Oct-2016 Completed Clinical Trials - General
3. Seed Round 30-Jun-2015 Completed Clinical Trials - General
2. Accelerator/Incubator 01-Jan-2015 Completed Clinical Trials - General
1. University Spin-Out 30-Apr-2014 Completed Startup
To view Healx’s complete valuation and funding history, request access »

Healx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C Preferred
Series B
Ordinary
Ordinary
Ordinary
Ordinary
Series B
Series A Ordinary
Series A Preferred 5,786,577 $0.000000 $1.5 $1.5 $1.5 14.22%
Ordinary 2,878,000 $0.000000 $0.67 $0.67 $0.67 7.07%
To view Healx’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Healx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an artificial intelligence-driven drug discovery technology designed to create treatments for rare diseases
Discovery Tools (Healthcare)
Cambridge, United Kingdom
69 As of 2026

South San Francisco, CA
 

San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Healx Competitors (28)

One of Healx’s 28 competitors is Xaira Therapeutics, a Venture Capital-Backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Xaira Therapeutics Venture Capital-Backed South San Francisco, CA
Verge Labs Venture Capital-Backed San Francisco, CA
Aitia Venture Capital-Backed Cambridge, MA
Exscientia Formerly VC-backed Oxford, United Kingdom
Onyx Venture Capital-Backed Berkeley, CA
You’re viewing 5 of 28 competitors. Get the full list »

Healx Patents

Healx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202509495-D0 Medical use Pending 16-Jun-2025
GB-202509498-D0 Medical use Pending 16-Jun-2025
GB-202509499-D0 Medical use Pending 16-Jun-2025
GB-202509233-D0 Treatment Pending 11-Jun-2025
GB-202507490-D0 Treatment Inactive 15-May-2025
To view Healx’s complete patent history, request access »

Healx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Healx Investors (26)

Investor Name Investor Type Holding Investor Since Participating Rounds
333VC Venture Capital Minority
Mandashi Venture Capital Minority
SCI Ventures (London) Venture Capital Minority
2468 Ventures Venture Capital Minority
AstraZeneca Corporation Minority
You’re viewing 5 of 26 investors. Get the full list »

Healx Acquisitions (2)

Healx’s most recent deal was a Merger/Acquisition with Vuja De Sciences. The deal was made on 28-Jul-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Vuja De Sciences 28-Jul-2025 Merger/Acquisition Drug Discovery
Nowomics 19-Aug-2017 Merger/Acquisition Business/Productivity Software
To view Healx’s complete acquisitions history, request access »

Healx FAQs

  • When was Healx founded?

    Healx was founded in 2014.

  • Where is Healx headquartered?

    Healx is headquartered in Cambridge, United Kingdom.

  • What is the size of Healx?

    Healx has 69 total employees.

  • What industry is Healx in?

    Healx’s primary industry is Discovery Tools (Healthcare).

  • Is Healx a private or public company?

    Healx is a Private company.

  • What is Healx’s current revenue?

    The current revenue for Healx is .

  • How much funding has Healx raised over time?

    Healx has raised $134M.

  • Who are Healx’s investors?

    333VC, Mandashi, SCI Ventures (London), 2468 Ventures, and AstraZeneca are 5 of 26 investors who have invested in Healx.

  • Who are Healx’s competitors?

    Xaira Therapeutics, Verge Labs, Aitia, Exscientia, and Onyx are some of the 28 competitors of Healx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process